201 related articles for article (PubMed ID: 34275172)
1. PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension.
Dasgupta A; Chen KH; Lima PDA; Mewburn J; Wu D; Al-Qazazi R; Jones O; Tian L; Potus F; Bonnet S; Archer SL
FASEB J; 2021 Aug; 35(8):e21771. PubMed ID: 34275172
[TBL] [Abstract][Full Text] [Related]
2. PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.
Ryan JJ; Marsboom G; Fang YH; Toth PT; Morrow E; Luo N; Piao L; Hong Z; Ericson K; Zhang HJ; Han M; Haney CR; Chen CT; Sharp WW; Archer SL
Am J Respir Crit Care Med; 2013 Apr; 187(8):865-78. PubMed ID: 23449689
[TBL] [Abstract][Full Text] [Related]
3. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy.
Xian H; Liou YC
Autophagy; 2019 Dec; 15(12):2107-2125. PubMed ID: 30894073
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
[TBL] [Abstract][Full Text] [Related]
5. Recombinant High-Mobility Group Box 1 (rHMGB1) Promotes NRF2-Independent Mitochondrial Fusion through CXCR4/PSMB5-Mediated Drp1 Degradation in Endothelial Cells.
Zhang S; Feng F; Dai J; Li J; Bu X; Xie X
Oxid Med Cell Longev; 2021; 2021():9993240. PubMed ID: 34394840
[TBL] [Abstract][Full Text] [Related]
6. Upregulated miR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2.
Lu Z; Li S; Zhao S; Fa X
Med Sci Monit; 2016 Sep; 22():3301-8. PubMed ID: 27640178
[TBL] [Abstract][Full Text] [Related]
7. Role of mitochondrial fusion proteins MFN2 and OPA1 on lung cellular senescence in chronic obstructive pulmonary disease.
Li C; Liu Q; Chang Q; Xie M; Weng J; Wang X; Li M; Chen J; Huang Y; Yang X; Wang K; Zhang N; Chung KF; Adcock IM; Zhang H; Li F
Respir Res; 2023 Dec; 24(1):319. PubMed ID: 38110986
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.
Dagda RK; Gusdon AM; Pien I; Strack S; Green S; Li C; Van Houten B; Cherra SJ; Chu CT
Cell Death Differ; 2011 Dec; 18(12):1914-23. PubMed ID: 21637291
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal Regulation of Mitofusin 2-Mediated Mitophagy and Mitochondrial Fusion by Different PINK1 Phosphorylation Events.
Li J; Dang X; Franco A; Dorn GW
Front Cell Dev Biol; 2022; 10():868465. PubMed ID: 35646911
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dynamics in pulmonary arterial hypertension.
Ryan J; Dasgupta A; Huston J; Chen KH; Archer SL
J Mol Med (Berl); 2015 Mar; 93(3):229-42. PubMed ID: 25672499
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the protein kinase A phosphorylation site influences the anti-proliferative activity of mitofusin 2.
Zhou W; Chen KH; Cao W; Zeng J; Liao H; Zhao L; Guo X
Atherosclerosis; 2010 Jul; 211(1):216-23. PubMed ID: 20303493
[TBL] [Abstract][Full Text] [Related]
12. Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma.
Lou Y; Li R; Liu J; Zhang Y; Zhang X; Jin B; Liu Y; Wang Z; Zhong H; Wen S; Han B
Med Oncol; 2015 Apr; 32(4):132. PubMed ID: 25796500
[TBL] [Abstract][Full Text] [Related]
13. Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.
Bhatia D; Chung KP; Nakahira K; Patino E; Rice MC; Torres LK; Muthukumar T; Choi AM; Akchurin OM; Choi ME
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31639106
[TBL] [Abstract][Full Text] [Related]
14. MFN2 deficiency affects calcium homeostasis in lung adenocarcinoma cells via downregulation of UCP4.
Zhang J; Pan L; Zhang Q; Zhao Y; Wang W; Lin N; Zhang S; Wu Q
FEBS Open Bio; 2023 Jun; 13(6):1107-1124. PubMed ID: 36877954
[TBL] [Abstract][Full Text] [Related]
15. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.
Rocha AG; Franco A; Krezel AM; Rumsey JM; Alberti JM; Knight WC; Biris N; Zacharioudakis E; Janetka JW; Baloh RH; Kitsis RN; Mochly-Rosen D; Townsend RR; Gavathiotis E; Dorn GW
Science; 2018 Apr; 360(6386):336-341. PubMed ID: 29674596
[TBL] [Abstract][Full Text] [Related]
16. The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes.
O'Flanagan CH; Morais VA; Wurst W; De Strooper B; O'Neill C
Oncogene; 2015 Mar; 34(11):1363-74. PubMed ID: 24681957
[TBL] [Abstract][Full Text] [Related]
17. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis.
Leboucher GP; Tsai YC; Yang M; Shaw KC; Zhou M; Veenstra TD; Glickman MH; Weissman AM
Mol Cell; 2012 Aug; 47(4):547-57. PubMed ID: 22748923
[TBL] [Abstract][Full Text] [Related]
18. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.
Chen Y; Dorn GW
Science; 2013 Apr; 340(6131):471-5. PubMed ID: 23620051
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.
Batt J; Ahmed SS; Correa J; Bain A; Granton J
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):74-86. PubMed ID: 23972212
[TBL] [Abstract][Full Text] [Related]
20. Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model.
Wang W; Liu X; Guo X; Quan H
Cell Physiol Biochem; 2018; 46(1):69-81. PubMed ID: 29587277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]